• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AXIOS STENT AND ELECTROCAUTERY ENHANCED DELIVERY SYSTEM; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AXIOS STENT AND ELECTROCAUTERY ENHANCED DELIVERY SYSTEM; PANCREATIC STENT, COVERED, METALLIC, REMOVABLE Back to Search Results
Device Problems Human-Device Interface Problem (2949); Activation Failure (3270); Device Stenosis (4066)
Patient Problems Fever (1858); Unspecified Infection (1930); Sepsis (2067)
Event Date 10/01/2017
Event Type  Injury  
Event Description
Boston scientific corporation became aware of the following event from referenced literature article "performance characteristics of a lumen-apposing metal stent for pancreatic fluid collections: a prospective cohort study." according to the literature, an axios stent and electrocautery enhanced delivery system was implanted to treat a pancreatic fluid collection during an endoscopic ultrasound-guided transmural drainage procedure performed on an unknown date.It was reported that the patient experienced fever and leukocytosis two days post stent placement.The patient underwent esophagogastroduodenoscopy (egd) procedure, and it was noted that the stent did not fully expand.The patient was treated with antibiotics and underwent a computed tomography (ct) scan.Stent ingrowth was also noted during the stent removal procedure.The stent was successfully removed using a rat tooth forceps.Another patient experienced abdominal sepsis and underwent a surgery.
 
Manufacturer Narrative
Exact date unknown, event occurred between october 2017 and september 2019.The complainant was unable to provide the suspect device upn and lot number.Therefore, the manufacture and expiration dates are unknown.Literature source: gurpal s, et al.Performance characteristics of a lumen-apposing metal stent for pancreatic fluid collections: a prospective cohort study.Journal of the canadian association of gastroenterology 2021: 4(4) p.3158-164.Imdrf device code a150101 captures the reportable event of stent failure to expand.Imdrf device code a0106 captures the reportable event of stent ingrowth.Imdrf patient code e1906 captures the reportable event of infection.Imdrf patient code e230101 captures the reportable event of fever.Imdrf patient code e0311 captures the reportable event of leukocytosis.Imdrf patient code e0306 captures the reportable event of abdominal sepsis.Imdrf impact code f2303 captures the reportable event of medication required.Imdrf impact code f23 captures the reportable event of additional interventions performed to address the patient complications.Imdrf impact code f19 captures the reportable event of surgery performed.
 
Manufacturer Narrative
Block b3: exact date unknown, event occurred between october 2017 and september 2019.Block d4, h4: the complainant was unable to provide the suspect device upn and lot number.Therefore, the manufacture and expiration dates are unknown.Block g2: literature source: gurpal s, et al.Performance characteristics of a lumen-apposing metal stent for pancreatic fluid collections: a prospective cohort study.Journal of the canadian association of gastroenterology 2021: 4(4) p.3158-164.Block h6: imdrf device code a150101 captures the reportable event of stent failure to expand.Imdrf device code a22 captures the reportable event of stent overgrowth.Imdrf patient code e1906 captures the reportable event of infection.Imdrf patient code e230101 captures the reportable event of fever.Imdrf patient code e0311 captures the reportable event of leukocytosis.Imdrf patient code e0306 captures the reportable event of abdominal sepsis.Imdrf impact code f2303 captures the reportable event of medication required.Imdrf impact code f23 captures the reportable event of additional interventions performed to address the patient complications.Imdrf impact code f19 captures the reportable event of surgery performed.Block h11: blocks h6 (device codes) and h10 have been corrected.
 
Event Description
Boston scientific corporation became aware of the following event from referenced literature article "performance characteristics of a lumen-apposing metal stent for pancreatic fluid collections: a prospective cohort study." according to the literature, an axios stent and electrocautery enhanced delivery system was implanted to treat a pancreatic fluid collection during an endoscopic ultrasound-guided transmural drainage procedure performed on an unknown date.It was reported that the patient experienced fever and leukocytosis two days post stent placement.The patient underwent esophagogastroduodenoscopy (egd) procedure, and it was noted that the stent did not fully expand.The patient was treated with antibiotics and underwent a computed tomography (ct) scan.Stent overgrowth was also noted during the stent removal procedure.The stent was successfully removed using a rat tooth forceps.Another patient experienced abdominal sepsis and underwent a surgery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIOS STENT AND ELECTROCAUTERY ENHANCED DELIVERY SYSTEM
Type of Device
PANCREATIC STENT, COVERED, METALLIC, REMOVABLE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key16350541
MDR Text Key309261061
Report Number3005099803-2023-00418
Device Sequence Number1
Product Code PCU
Combination Product (y/n)N
Reporter Country CodeCA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/10/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/21/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-